عنوان
پدید آورنده
موضوع
رده
RC271.C5 A6722 2004
RC271
.
C5
A6722
2004
کتابخانه
محل استقرار
INTERNATIONAL STANDARD BOOK NUMBER
(Number (ISBN
1588292282 (alk. paper)
(Number (ISBN
1592597394 (e-book)
NATIONAL BIBLIOGRAPHY NUMBER
Number
b517408
TITLE AND STATEMENT OF RESPONSIBILITY
Title Proper
Anticancer drug development guide :
General Material Designation
[Book]
Other Title Information
preclinical screening, clinical trials, and approval /
First Statement of Responsibility
edited by Beverly A. Teicher, Paul A. Andrews
EDITION STATEMENT
Edition Statement
2nd ed
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Totowa, N.J. :
Name of Publisher, Distributor, etc.
Humana Press,
Date of Publication, Distribution, etc.
c2004
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
xiv, 450 p. :
Other Physical Details
ill. ;
Dimensions
26 cm. +
Accompanying Material
1 CD-ROM (4 3/4 in.)
SERIES
Series Title
Cancer drug discovery and development
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
Includes bibliographical references and index
CONTENTS NOTE
Text of Note
Drug development in Europe: the academic perspective / Chris Twelves ... [et al.] -- The phase III clinical cancer trial / Ramzi N. Dagher and Richard Pazdur -- Assessing tumor-related symptoms and health-related quality of life in cancer clinical trials: a regulatory perspective / Judy H. Chiao, Grant Williams, and Donna Griebel -- The role of the oncology drug advisory committee in the FDA review process for oncologic products / Leslie A. Vaccari -- FDA role in cancer drug development and requirements for approval / Susan Flamm Honig
Text of Note
High-volume screening / Michel Pagä -- High-throughput screening in industry / Michael D. Boisclair ... [et al.] -- The NCI human tumor cell line (60-cell) screen: concept, implementation, and applications / Michael R. Boyd -- Human tumor screening / Axel-R. Hanauske, Susan G. Hilsenbeck, and Daniel D. Von Hoff -- Murine L1210 and P388 leukemias / William R. Waud -- In vivo methods for screening and preclinical testing: use of rodent solid tumors for drug discovery / Thomas Corbett ... [et al.] -- Human tumor xenograft models in NCI drug development / Michael C. Alley ... [et al.] -- Specialized in vitro/in vivo procedures employed by the NCI in preclinical drug evaluations / Melinda G. Hollingshead ... [et al.] --
Text of Note
Patient-like orthotopic metastatic models of human cancer / Robert M. Hoffman -- Preclinical models for combination therapy / Beverly A. Teicher -- Models for biomarkers and minimal residual tumor / Beverly A. Teicher -- Spontaneously occurring tumors in companion animals as models for drug development / David M. Vail and Douglas H. Thamm -- Nonclinical testing: from theory to practice / Denis Roy and Paul A. Andrews -- Nonclinical testing for oncology drug products / Paul A. Andrews and Denis Roy -- Nonclinical testing for oncology biologic products / Carolyn M. Laurenìot, Denis Roy, and Paul A. Andrews --
Text of Note
Working with the national cancer institute / Paul Thambi and Edward A. Sausville -- Phase I trial design and methodology for anticancer drugs / Patrick V. Acevedo, Deborah L. Toppmeyer, and Eric H. Rubin -- Phase II trials: conventional design and novel strategies in the era of targeted therapies / Keith T. Flaherty and Peter J. O'Dwyer --
0
0
0
0
SYSTEM REQUIREMENTS NOTE (ELECTRONIC RESOURCES)
Text of Note
Minimum system requirements: Adobe reader 6.0 or later
TOPICAL NAME USED AS SUBJECT
Antineoplastic agents-- Development
DEWEY DECIMAL CLASSIFICATION
Number
616
.
99/4061
Edition
22
LIBRARY OF CONGRESS CLASSIFICATION
Class number
RC271
.
C5
Class number
RC271
.
C5
Book number
A6722
2004
Book number
A6722
2004
OTHER CLASS NUMBERS
Class number
2004
D-110
Class number
QV
269
Book Number
A62953
2004
PERSONAL NAME - ALTERNATIVE RESPONSIBILITY
Andrews, Paul A
Teicher, Beverly A.,1952-
ORIGINATING SOURCE
Date of Transaction
20040818172835.0
ELECTRONIC LOCATION AND ACCESS
Electronic name
مطالعه متن کتاب [Book]
Y
